ROCKVILLE, MD – February 16, 2021 – DP Clinical, Inc., a Contract Research Organization (CRO) located in Rockville, Maryland, announces James (Jim) Hamer, Director, Spinal Cord Injury (SCI) Programs, at DP Clinical has been elected to the Board of Directors for Unite 2 Fight Paralysis (U2FP) organization and will serve a three-year term. U2FP’s mission is to unite and empower the international spinal cord injury community to cure paralysis through advocacy, education, and support for research.

“With more than 24 years of SCI research and clinical trial experience, Jim will bring a critical perspective to the Board,” stated Devinder Poonian, President and CEO of DP Clinical.  “During his career, Jim has managed numerous acute and chronic SCI clinical trials including those with pharmaceuticals, autologous macrophages, the first in human sub-acute stem cell trials, as well as device studies.  DP Clinical started as an SCI CRO, and we look forward to witnessing one-day soon a curative therapy for this debilitating injury,” continued Ms. Poonian.